vs
Side-by-side financial comparison of JFrog Ltd (FROG) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $145.3M, roughly 1.4× JFrog Ltd). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -10.5%, a 13.1% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 25.2%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 20.4%).
JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
FROG vs IRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $145.3M | $208.9M |
| Net Profit | $-15.2M | $5.6M |
| Gross Margin | 77.9% | 70.9% |
| Operating Margin | -14.7% | 1.1% |
| Net Margin | -10.5% | 2.7% |
| Revenue YoY | 25.2% | 27.1% |
| Net Profit YoY | 34.4% | 518.5% |
| EPS (diluted) | $-0.13 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $145.3M | $208.9M | ||
| Q3 25 | $136.9M | $192.9M | ||
| Q2 25 | $127.2M | $186.7M | ||
| Q1 25 | $122.4M | $158.7M | ||
| Q4 24 | $116.1M | $164.3M | ||
| Q3 24 | $109.1M | $147.5M | ||
| Q2 24 | $103.0M | $148.0M | ||
| Q1 24 | $100.3M | $131.9M |
| Q4 25 | $-15.2M | $5.6M | ||
| Q3 25 | $-16.4M | $-5.2M | ||
| Q2 25 | $-21.7M | $-14.2M | ||
| Q1 25 | $-18.5M | $-30.7M | ||
| Q4 24 | $-23.2M | $-1.3M | ||
| Q3 24 | $-22.9M | $-46.2M | ||
| Q2 24 | $-14.3M | $-20.1M | ||
| Q1 24 | $-8.8M | $-45.7M |
| Q4 25 | 77.9% | 70.9% | ||
| Q3 25 | 77.4% | 71.1% | ||
| Q2 25 | 76.3% | 71.2% | ||
| Q1 25 | 75.3% | 68.8% | ||
| Q4 24 | 75.4% | 70.0% | ||
| Q3 24 | 75.0% | 68.8% | ||
| Q2 24 | 78.8% | 69.9% | ||
| Q1 24 | 79.5% | 66.3% |
| Q4 25 | -14.7% | 1.1% | ||
| Q3 25 | -15.8% | -4.4% | ||
| Q2 25 | -20.4% | -10.0% | ||
| Q1 25 | -18.8% | -20.5% | ||
| Q4 24 | -21.9% | -2.5% | ||
| Q3 24 | -27.4% | -34.1% | ||
| Q2 24 | -18.6% | -15.5% | ||
| Q1 24 | -16.6% | -28.9% |
| Q4 25 | -10.5% | 2.7% | ||
| Q3 25 | -12.0% | -2.7% | ||
| Q2 25 | -17.0% | -7.6% | ||
| Q1 25 | -15.1% | -19.3% | ||
| Q4 24 | -20.0% | -0.8% | ||
| Q3 24 | -21.0% | -31.3% | ||
| Q2 24 | -13.9% | -13.6% | ||
| Q1 24 | -8.8% | -34.6% |
| Q4 25 | $-0.13 | $0.18 | ||
| Q3 25 | $-0.14 | $-0.16 | ||
| Q2 25 | $-0.19 | $-0.44 | ||
| Q1 25 | $-0.16 | $-0.97 | ||
| Q4 24 | $-0.21 | $-0.03 | ||
| Q3 24 | $-0.21 | $-1.48 | ||
| Q2 24 | $-0.13 | $-0.65 | ||
| Q1 24 | $-0.08 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $704.4M | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $887.4M | $152.7M |
| Total Assets | $1.3B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $704.4M | $583.8M | ||
| Q3 25 | $651.1M | $565.2M | ||
| Q2 25 | $611.7M | $545.5M | ||
| Q1 25 | $563.5M | $520.6M | ||
| Q4 24 | $522.0M | $535.6M | ||
| Q3 24 | $467.8M | $522.0M | ||
| Q2 24 | $591.3M | $561.5M | ||
| Q1 24 | $579.6M | $569.1M |
| Q4 25 | $887.4M | $152.7M | ||
| Q3 25 | $859.4M | $121.9M | ||
| Q2 25 | $826.5M | $103.7M | ||
| Q1 25 | $800.0M | $86.7M | ||
| Q4 24 | $773.5M | $90.9M | ||
| Q3 24 | $756.2M | $71.8M | ||
| Q2 24 | $721.4M | $99.2M | ||
| Q1 24 | $707.8M | $90.3M |
| Q4 25 | $1.3B | $1.0B | ||
| Q3 25 | $1.3B | $995.2M | ||
| Q2 25 | $1.2B | $964.0M | ||
| Q1 25 | $1.2B | $926.1M | ||
| Q4 24 | $1.1B | $931.4M | ||
| Q3 24 | $1.1B | $909.7M | ||
| Q2 24 | $1.0B | $919.2M | ||
| Q1 24 | $997.1M | $909.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $50.7M | $26.2M |
| Free Cash FlowOCF − Capex | $49.9M | $14.5M |
| FCF MarginFCF / Revenue | 34.3% | 6.9% |
| Capex IntensityCapex / Revenue | 0.6% | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | $142.3M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $50.7M | $26.2M | ||
| Q3 25 | $30.2M | $34.9M | ||
| Q2 25 | $36.1M | $27.7M | ||
| Q1 25 | $28.8M | $-7.9M | ||
| Q4 24 | $49.1M | $19.2M | ||
| Q3 24 | $27.6M | $24.3M | ||
| Q2 24 | $16.7M | $11.8M | ||
| Q1 24 | $17.5M | $-52.0M |
| Q4 25 | $49.9M | $14.5M | ||
| Q3 25 | $28.8M | $20.1M | ||
| Q2 25 | $35.5M | $17.3M | ||
| Q1 25 | $28.1M | $-17.3M | ||
| Q4 24 | $48.5M | $12.4M | ||
| Q3 24 | $26.7M | $15.5M | ||
| Q2 24 | $16.0M | $3.4M | ||
| Q1 24 | $16.6M | $-61.8M |
| Q4 25 | 34.3% | 6.9% | ||
| Q3 25 | 21.0% | 10.4% | ||
| Q2 25 | 27.9% | 9.3% | ||
| Q1 25 | 23.0% | -10.9% | ||
| Q4 24 | 41.8% | 7.5% | ||
| Q3 24 | 24.5% | 10.5% | ||
| Q2 24 | 15.5% | 2.3% | ||
| Q1 24 | 16.6% | -46.8% |
| Q4 25 | 0.6% | 5.6% | ||
| Q3 25 | 1.0% | 7.7% | ||
| Q2 25 | 0.5% | 5.6% | ||
| Q1 25 | 0.5% | 5.9% | ||
| Q4 24 | 0.5% | 4.2% | ||
| Q3 24 | 0.9% | 6.0% | ||
| Q2 24 | 0.7% | 5.7% | ||
| Q1 24 | 0.8% | 7.4% |
| Q4 25 | — | 4.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FROG
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
